0 Bewertungen0% fanden dieses Dokument nützlich (0 Abstimmungen)
75 Ansichten2 Seiten
Genentech appeals to the U.S. Court of Appeals for the Federal Circuit a July 18 denial of request for preliminary injunction against Amgen regarding its biosimilar version of Herceptin.
Genentech appeals to the U.S. Court of Appeals for the Federal Circuit a July 18 denial of request for preliminary injunction against Amgen regarding its biosimilar version of Herceptin.